GFAP and Huntington disease: To address the cell type specificity of the lamin B1 increase, we performed NeuN and lamin B1 co‐immunostaining (with or without GFAP), in brain sections obtained from 30‐week‐old R6/1 mice and from HD patients at different stages of the disease, and their corresponding controls.